Probing the role of the covalent linkage of ferrocene into a chloroquine template

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4707-4714

  Biot, Christophe ^a   Daher, Wassim ^b   Ndiaye, Cheikh M ^a   Melnyk, Patricia ^c   Pradines, Bruno ^d   Chavain, Natascha ^a   Pellet, Alain ^e   Fraisse, Laurent ^e   Pelinski, Lydie ^a   Jarry, Christian ^f   Brocard, Jacques ^a   Khalife, Jamal ^b   Forfar Bares, Isabelle ^f   Dive, Daniel ^b  

^a UNITÉ DE CATALYSE ET DE CHIMIE DU SOLIDE   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d SERVICE DE SANTÉ DES ARMÉES   (France)

^e SANOFI   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE; ALIPHATIC AMINE; CHLOROQUINE; FERROCENE; FERROQUINE; HEMATIN; N4 [2 [ETHYL(METHYL)AMINO]METHYLFERROCENYL] 7 CHLORO 4 QUINOLAMINE; SR 97276; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; COVALENT BOND; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM;

EID: 33746727034     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060259d     Document Type: Article

References (22)

1. Biagini, G. A.; O'Neill, P. M.; Bray, P. G.; Ward, S. A. Current drug development portfolio for antimalarial therapies. Curr. Opin. Pharmacol. 2005, 5, 473-478.
2. Baird, J. K. Effectiveness of antimalarial drugs. N. Engl. J. Med. 2005, 352, 1565-1577.
3. Ballou, W. R.; Arevalo-Herrera, M.; Carucci, D.; Richie, T. L.; Corradin, G.; Diggs, C.; Druilhe, P.; Giersing, B. K.; Saul, A.; Heppner, D. G.; Kester, K. E.; Lanar, D. E.; Lyon, J.; Hill, A. V.; Pan, W.; Cohen, J. D. Update on the clinical development of candidate malaria vaccines. Am. J. Trop. Med. Hyg. 2004, 71, 239-247.
4. Greenwood, B. M.; Bojang, K.; Whitty, C. J.; Targett, G. A. Malaria Lancet 2005, 365, 1487-1498.
5. Pink, Richard; Hudson, A.; Mouris, M.-A.; Bendig, M. Opportunities and Challenges in Antiparasitic Drug Discovery. Nature Rev. Drug Discovery 2005, 4, 727-740.
6. Biot, C.; Chibale, K. Novel approaches to antimalarial drug discovery. Infect. Disord. Drug Targets 2006, 6, 173-204.
7. Kapoor, V. K.; Kumar, K. Recent advances in the search for newer antimalarial agents. Prog. Med. Chem. 2005, 43, 189-237.
8. For a detailed review about ferroquine, see: Biot, C. Ferroquine: a new weapon in the fight against malaria. Curr. Med. Chem.: Anti-infect. Agents 2004, 3, 135-147.
9. Biot, C.; Taramelli, D.; Forfar-Bares, I.; Maciejewski, L. A.; Boyce, M.; Nowogrocki, G.; Brocard, J. S.; Basilico, N.; Olliaro, P.; Egan, T. J. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol. Pharm. 2005, 2, 185-193.
10. Ridley, R. G.; Hofheinz, W.; Matile, H.; Jaquet, C.; Dorn, A.; Masciadri, R.; Jolidon, S.; Richter, W. F.; Guenzi, A.; Girometta, M. A.; Urwyler, H.; Huber, W.; Thaitong, S.; Peters, W. 4-Amino-quinoline Analogs of Chloroquine with Shortened Side Chains Retain Activity Against Chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 1996, 40, 1846-1854.
11. De, D.; Krogstad, F. M.; Byers, L. D.; Krogstad, D. J. Structure-Activity Relationships for Antiplasmodial Activity among 7-Substituted 4-Aminoquinolines. J. Med. Chem. 1998, 41, 4918-4926.
12. Chibale, K.; Moss, J. R.; Blackie, M.; van Schalkwyk, D.; Smith, P. J. New amine and urea analogs of ferrochloroquine: synthesis, antimalarial activity in vitro and electrochemical studies. Tetrahedron Lett. 2000, 41, 6231-6235.
13. Beagley, P.; Blackie, M. A. L.; Chibale, K.; Clarkson, C.; Mos, J. R.; Smith, P. J. Synthesis and antimalarial activity in vitro of new ruthenocene-chloroquine analogs. J. Chem. Soc., Dalton Trans. 2002, 4426-4433.
14. Borch, R. F.; Durst, H. D. Lithium cyanohydridoborate, a versatile new reagent. J. Am. Chem. Soc. 1969, 91, 3996-3997.
15. Borch, R. F.; Bernstein, M. D.; Durst, H. D. Cyanohydridoborate anion as a selective reducing agent. J. Am. Chem. Soc. 1971, 93, 2897-2904.
16. Biot, C.; Delhaes, L.; N'Diaye, C. M.; Maciejewski, L. A.; Camus, D.; Dive, D.; Brocard, J. S. Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds. Bioorg. Med. Chem. 1999, 7, 2843-2847.
17. Daher, W.; Pelinski, L.; Klieber, S.; Sadoun, F.; Meunier, V.; Bourrie, M.; Biot, C.; Guillou, F.; Fabre, G.; Brocard, J.; Fraisse, L.; Maffrand, J. P.; Khalife, J.; Dive, D. In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum. Drug Metab. Dispos. 2006, 34, 667-682.
18. Parapini, S.; Basilico, N.; Pasini, E.; Egan, T. J.; Olliaro, P.; Taramelli, D.; Monti, D. Standardization of the physicochemical parameters to assess in vitro the β-hematin inhibitory activity of antimalarial drugs. Exp. Parasitol. 2000, 96, 249-256.
19. Déprez-Poulain, R.; Melnyk, P. 1,4-bis(3-aminopropyl)-piperazine libraries: from the discovery of classical chloroquine-like antimalarials to the identification of new targets. Comb. Chem. High Throughput Screen. 2005, 8, 39-48.
20. Warhust, D. C.; Craig, J. C.; Agadu, I. S.; Meyer, D. J.; Lee, S. Y. The relationships of physicochemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Malaria J. 2003, 2, 26-40.
21. The lack of correlation is also striking in Figure 2, where the compounds have been distributed as a function of increasing log D (pH = 5.2) values.
22. Kaschula, C. H.; Egan, T. J.; Hunter, R.; Basilico, N.; Parapini, S.; Pasini, E.; Monti, D. Structure-activity relationships in 4-amino-quinoline antiplasmodials. The role of the group at the 7-position. J. Med. Chem. 2002, 45, 3531-3539.